|
|
- NEWSLETTERS
- MOBILE APPS
-
ADD TIME NEWS
Cancer Drugs
HERCEPTIN
Action: Antigrowth
Target cancer: Breast cancer
Manufacturer: Genentech
Side effects: Fever and chills; in rare cases, heart problems and potentially fatal allergic reactions
Cost: About $700 for a week's worth of injections. In clinical trials, the median time on Herceptin was 36 weeks.
Total cost: $25,000
RITUXAN
Action: Targeted cell destruction
Target cancer: Non-Hodgkin's lymphoma
Manufacturer: Genentech/IDEC
Side effects: Fever and chills; in
rare cases, low blood pressure and potentially fatal allergic reactions
Cost: $10,000 for the full four-week treatment. Retreatment is possible for relapse.
Total cost: $10,000-$20,000
CAMPATH
Action: Targeted cell destruction
Target cancer: Chronic lymphocytic leukemia
Manufacturer: Millennium/Ilex
Side effects: Fever and chills, infections
and sometimes severe anemia; in rare cases, potentially fatal allergic reactions
Cost: A pricing plan has not yet been released
for the infusions, which are delivered three times
a week for as long as 12 weeks
GLEEVEC
Action: Antigrowth
Target cancer: Chronic myeloid leukemia
Manufacturer: Novartis
Side effects: Swelling, cramps, nausea and in some cases severe anemia. It's too early for researchers to determine whether there are long-term safety problems
Cost: $2,400 for a month's worth. No one is sure, but treatment could be three years to a lifetime.
Total cost: $86,000
Drugs In The Pipeline
Of the 402 experimental cancer treatments listed on the Pharmaceutical Research and Manufacturers of America website (phrma.org), many are traditional chemotherapy agents. But a growing number are part of the new breed. Here are a few of them:
head and neck
Tarceva Antigrowth agent
(Genentech/OSI/Roche)
lymph system
Bexxar Delivers a dose of radiation directly to cancer cells
(Corixa/GlaxoSmithKLine)
lungs
Iressa Antigrowth agent
(AstraZeneca)
GVAX Immune-system booster
(Cell Genesys)
Neovastat Antiangiogenesis agent
(AEterna)
pancreas
Virulizin Immune-system booster
(Lorus Therapeutics)
colon
celecoxib May act to prevent cancer
(Pharmacia/Pfizer)
semaxanib Antiangiogenesis
(Pharmacia/SUGEN)
IMC-C225 Antigrowth agent
(ImClone Systems)
skin
Genasense Triggers cell suicide
(Genta)
![]() |
![]() |
![]() |
Most Popular »
- Autism Numbers Are Rising. The Question is Why?
- Israel vs. Hizballah: Drumbeats of War
- The Pentagon Prepares for a Missile Attack from 'Iran'
- And the Decade Goes To ...
- Mexico Takes Down a Drug Lord. But Will It Make Any Difference?
- Tech Guide
- The Young Victoria: How a Queen Shapes Her Destiny
- Why You Can't Trust the Press
- Avatar Arrives! Can James Cameron Be King Again?
- Tiger Woods' Sponsors: Will Any Stick by Him?
- Autism Numbers Are Rising. The Question is Why?
- Yemen's Hidden War: Is Iran Causing Trouble?
- Detroit's Last White City Council Member
- Super-Earth: Astronomers Find a Watery New Planet
- GM Keeps Opel, Announces Job Cuts, Angers Germans
- Avatar Arrives! Can James Cameron Be King Again?
- Corliss Appraises Avatar: A World of Wonder
- Parents' Sex Talk with Kids: Too Little, Too Late
- Dwindling Death Penalty: Victim of the Recession?
- Spotlight: Paying for the Afghan War








RSS